| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 912.3K | $3.44M | - | |
| 10% | 478.7K | $1.80M | - | |
| 10% | 198.9K | $749.8K | - | |
| CEO | 55.4K | $208.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | David J Matlin | Director | Buy | 149,610 | $2.50 | $374,771.10 | +6.6% | +26.6% | -64.0% | |
| Jun 16, 2022 | Mark Mortenson | Chief Science Officer | Sell | 20,247 | $2.47 | $50,010.09 | -10.7% | +13.8% | -67.2% | |
| Jun 15, 2022 | Alison Mosca | Director | Buy | 5,000 | $2.62 | $13,100.00 | +14.5% | +6.0% | -60.4% | |
| Jun 15, 2022 | David J Matlin | Director | Buy | 96,011 | $2.66 | $255,389.26 | +4.4% | +6.0% | -60.4% | |
| Jun 13, 2022 | David J Matlin | Director | Buy | 55,000 | $3.06 | $168,300.00 | +2.6% | -5.2% | -65.7% | |
| Jun 6, 2022 | David J Matlin | Director | Buy | 60,670 | $2.55 | $154,821.90 | +2.9% | -0.7% | -61.5% | |
| May 27, 2022 | David J Matlin | Director | Buy | 35,000 | $2.27 | $79,450.00 | +1.7% | +43.0% | -58.6% | |
| May 16, 2022 | General Resonance LLC63 | 10% Owner | Sell | 181,818 | $2.20 | $399,999.60 | -1.2% | +70.6% | -57.9% | |
| May 16, 2022 | Robert Glanzman | Chief Medical Officer | Sell | 4,717 | $2.03 | $9,575.51 | -30.9% | +70.6% | -57.9% | |
| May 16, 2022 | Jonathon Gay | Director | Buy | 10,000 | $2.08 | $20,800.00 | +17.0% | +70.6% | -57.9% |